Neil E. Fleshner - Mar 29, 2022 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Chief Medical Officer, Director
Signature
/s/ William L. Demers, by Power of Attorney for Neil E. Fleshner
Stock symbol
PNT
Transactions as of
Mar 29, 2022
Transactions value $
$0
Form type
4
Date filed
3/31/2022, 04:57 PM
Previous filing
Jul 8, 2021
Next filing
May 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +60.2K $0.00 60.2K Mar 29, 2022 Common Stock 60.2K $8.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.